Issue Contents:

Pacific Fertility Center

55 Francisco Street,
Suite 500
San Francisco,
CA 94133
TEL: 888-834-3095
FAX: 415-834-3080
www.InfertilityDoctor.com
Info@PacificFertility.com



Our Promise

As a unified team, guided by the highest ethical standards, we provide our patients with the best quality, individualized, compassionate fertility care.
Science Pulse    Abnormal Fertilization


Twenty-four hours after undergoing an egg retrieval procedure, a patient will receive a fertilization report. Occasionally the report will indicate that some of their eggs fertilized abnormally. This article explains the process of scoring fertilization and explains the results.

During an egg retrieval procedure, an embryologist, with the aid of a microscope, quickly identifies and takes custody of the eggs. They are immediately placed inside an incubator in our laboratory where they mature for 4 hours before being introduced to sperm. Then, depending on the quality of the sperm, an embryologist will either incubate each egg in the presence of 100,000 sperm, or inject a single sperm into each egg (in a process called Intracytoplasmic Sperm Injection or ICSI).

The next morning, 22 hours after the egg retrieval, an embryologist observes the eggs and records their fertilization status. A small percentage of eggs will be immature or non-viable. The remainder can fertilize normally, fail to fertilize or fertilize abnormally.

As fertilization gets underway and the sperm is working its way into the egg, the egg is busy completing the process of duplicating, then ejecting half of the female DNA. This reduction in DNA content, a process called meiosis, is completed only when the egg is fertilized; the sperm actually stimulates the egg to finish meiosis.

Meiosis happens in two distinct stages in eggs. The first stage is completed in the hours before ovulation or before a retrieval procedure, and readies the egg to receive the sperm. The egg discards some DNA in a small structure called a polar body (PB), and the presence of this 1st PB tells us that the egg is mature and can be fertilized (see Figure 1). The second stage of meiosis is very similar to the first, and it generates a second PB, but an egg will only complete this stage if penetrated by a sperm (both polar bodies are visible in Figure 2).

Once inside the egg, the sperm head swells and forms a structure called a pronucleus. The term “pronucleus” is used because it only contains half the DNA of a normal human nucleus. The egg responds by completing meiosis (ejecting the 2nd PB) and creating another pronucleus. The egg now has the right amount of DNA needed to create a new individual (˝ from the male (sperm) and ˝ from the female (egg)) and the 2 pronuclei are clearly visible in the center of the egg (see Figure 2). The egg has fertilized normally and this is confirmed by the presence of 2 polar bodies.

If we don't see any pronuclei (Figure 1), we assume that fertilization has failed. In this instance the sperm doesn't show up as a pronucleus inside the egg, and in the absence of a sperm, the egg doesn't complete meiosis. This lack of pronuclei indicates fertilization failure, and the presence of just a single PB confirms this finding (Figure 1).

While performing fertilization checks, the embryologist will observe either no pronuclei or 2 pronuclei in the vast majority of eggs. However, a small number of eggs, usually around 5% of all eggs inseminated, will show some number other than none or two pronuclei (see Figures 3, 4 and 5). These are the eggs that are abnormally fertilized.

Having more than 2 pronuclei usually suggests that more than 1 sperm managed to enter the egg. If this happens, there is one nucleus from the egg and one nucleus for each sperm that got in. An egg penetrated by 3 sperm for example, will have 4 pronuclei (see Figure 5). Please note that the egg has 3 separate mechanisms to prevent penetration by more than one sperm, so eggs with >2 pronuclei are uncommon.

Occasionally, an egg into which we only injected one sperm will show up with 3 pronuclei (Figure 3). When this happens we suspect that the egg did not complete meiosis and in fact retained the ˝ of the female DNA that it was supposed to discard in the 2nd PB. Such an egg would have 2 maternal pronuclei, and one paternal pronucleus. Regardless of the source of the extra nucleus, any number of pronuclei above 2 is abnormal and the resulting embryo is anomalous by virtue of having too much DNA, and it cannot result in a baby.

The other abnormality that we see is the presence of only a single pronucleus in the egg (Figure 4). This particular situation can arise in a number of ways, but it most often arises because the egg attempts to develop into an embryo without fertilization by a sperm. This process is called parthenogenesis, and without any male DNA, the embryo will typically die within a few days. Alternatively, if there's a slight acceleration or lag in the appearance of a pronucleus, we might only see one nucleus when we look. Genetic studies have helped in understanding the status of single pronucleate embryos: If the condition arises after sperm injection, where we know the precise time of sperm entry, up to 90% of the resulting embryos are abnormal. However, if a single pronucleus is seen after a normal insemination, where we don't know the exact time of sperm entry, or the maturity of the egg at insemination, over 60% of these embryos turn out to be normal.

We find that viable embryos mainly result from eggs with 2 pronuclei. Embryos arising from eggs with more than 2 pronuclei, or from eggs that were injected and had only a single pronucleus, are discarded as they are almost certainly genetically abnormal.

But fertilization is a transient process between egg and embryo. Pronuclei are only visible in the egg for a few hours and it is possible to miss one or more of them. Hence, we occasionally have embryos resulting from eggs where we didn't observe any pronuclei, or where we saw only a single pronucleus after incubating the egg with sperm. In these embryos, we can't be certain that they are normal. Typically, we keep them in our laboratory for at least an additional 2 days and watch their development carefully. If they behave like normal embryos, we can transfer them or freeze them for later use. It is important to note that we would only use these embryos if a patient had few or no normally fertilized embryos. If after transfer these embryos turn out to be abnormal, they would not implant and thus not result in a pregnancy.

When examining eggs for pronuclei, the embryologist looks very carefully at the pronuclear and polar body status of each individual egg, using an inverted microscope that can magnify up to 400 times. Small clues, such as the subtlety large size of the pronucleus in Figure 4, can explain what is happening. This egg is abnormal because the nucleus is too big to have come from a sperm. Without a sperm to fertilize the egg, it cannot complete meiosis and expel the 2nd polar body. The nucleus is therefore bigger than normal as it contains the DNA that an egg normally retains, plus the DNA that should have been discarded in the 2nd PB. We would have no choice but to discard this egg.

We generally transfer embryos that show the normal 2 pronuclei when observed on the day after egg retrieval. We are careful only to discard embryos that we see for certain are abnormal at fertilization. If for any reason we are unsure, we will give an embryo the benefit of the doubt if it displays normal growth patterns after fertilization.

We give patients their individual fertilization information on the day after their retrieval and discuss it again on transfer day. The hope is that you will clearly understand the fate of each of your retrieved eggs and we allow ample time for discussion if you have questions.
- Joe Conaghan, PhD, HCLD

Joe Conaghan, PhD, HCLD, PFC's ART Laboratory Director, is internationally recognized for his work with embryos. His background includes involvement in the first PGD on human embryos. His high standards and extensive experience brings national recognition to our laboratory. He also trains fellow embryologists for licensure and is an inspector for CAP, the licensing body for IVF laboratories in the USA.


Photo Gallery    Scoring Fertilization

The morning after egg retrieval and the introduction of the egg to sperm, an embryologist observes the eggs and records their fertilization status. The following photographs reveal what the embryologist may see and the factors they examine when evaluating fertilization.


This is a mature, unfertilized egg. The presence of a polar body (circled in red) indicates that the egg was mature and ready to be fertilized. The absence of pronuclei and a 2nd polar body indicates that the egg failed to fertilize. Note the single sperm (arrow) attached to the outside of the eggshell.


This is a normally fertilized egg with two pronuclei (circled in blue) and two polar bodies (circled in red).


This is an abnormally fertilized egg with three pronuclei (circled in blue). In this case, because there is only one polar body, (circled in red), we would suspect that there are 2 maternal pronuclei in addition to the paternal pronucleus.


This is an abnormally fertilized egg with only one pronucleus, (circled in blue) and one polar body (circled in red).


This is an abnormally fertilized egg with four pronuclei (circled in blue).


Conception Health    About Prolactin

Prolactin is a protein hormone produced in the pituitary gland that controls lactation. This hormone in women is normally produced at low levels except after birth, when suckling at the breast stimulates secretion of breast milk. Prolactin inhibits reproductive hormones and during breast-feeding is responsible for decreasing the chances of conception during the postpartum period.

A relatively common benign tumor of the pituitary can result in the over-secretion of prolactin. If this happens, a woman may develop galactorrhea, or inappropriate secretion of breast milk when not in the postpartum (after birth) period. If the levels of prolactin are high, she may develop a short luteal phase (second half of the menstrual cycle) or even stop ovulating altogether.

There are many causes of high prolactin levels, such as diet, stress, breast stimulation, and exercise. Occasionally, a small growth, or tumor, of the pituitary can be responsible. If the levels of prolactin are high, a woman will be advised to undergo an MRI of the pituitary gland to determine whether a tumor is present, and, if so, its size. If it is less than one centimeter in diameter, it is called a microadenoma. If it is greater than one centimeter, it is called a macroadenoma. Macroadenomas can cause pressure on the optic nerve, leading to headaches and partial visual loss in some cases.

Most of the time, high prolactin levels can be treated with either bromocriptine (Parlodel) or cabergoline (Dostinex). These medications will usually shrink the tumor size and restore the prolactin levels to the normal range. If the medications do not shrink the tumor and symptoms persist, a surgical procedure to remove the tumor known as a “trans-sphenoidal resection” will be advised. Surgery today is rarely performed.

Many women will be found to have mildly elevated levels of prolactin with no apparent symptoms. At these levels, there are rarely symptoms of galactorrhea, anovulation or headaches and visual changes and an MRI is not necessary. However, if the woman is trying to conceive, it is recommended that she start medication to restore the prolactin levels to the normal range. Even mild elevations of prolactin can be associated with infertility. Usually, the medications are discontinued once pregnancy occurs. The only women that are advised to continue Parlodel or Dostinex during pregnancy are those with confirmed macroadenomas (large pituitary tumors), as they can grow in pregnancy and cause optic nerve compression.

There are some things that can result in mild and transient elevations of prolactin. These include nipple stimulation, a high protein meal, birth control pills (sometimes) and some psychiatric medications such as phenothiazines for psychosis. These should be avoided just prior to having prolactin levels drawn.
- Carolyn Givens, MD


Ask the Experts    Heredity and Fertility


Q.
My grandmother had a daughter (my mother) pretty late in her life – I believe she was 42! Can I count on being fertile at this late age?

A.
Aging of the egg is a complex event. It is possible that the eggs of mothers and daughters age similarly, and that some of what we see as age-related infertility may be genetically determined. We have not identified any definitive research, but there is suggestive evidence that late age fecundity is passed from one female generation to another.


It is clear that the age at menopause runs in families. The average age at menopause is 49, but a few women enter menopause in their 20s or 30s and some in their 50s or 60s. The strongest predictor of a woman's age at menopause is her mother's age at menopause.

In certain population clusters there are women that show very high natural fecundity. In these groups, the women are closely related, and they continue to attempt conception into later years. Very high natural fertility rates can occur into the late forties.

There are some chromosomal abnormalities that can cause premature menopause that can be inherited. An example is a Turner's mosaic, where a woman is missing a piece of her X-chromosome. This problem is associated with premature menopause, and can be passed from mother to daughter.

Many non-genetic factors determine late-life fertility, such as use of birth control, degree of sexual activity, and medical problems that affect the uterus and ovaries. Some of these factors are determined by personal choice, and some are events that occur naturally. Many are not genetically determined.

The determinants of fertility are complex; many factors play a role in fecundity. Until dedicated research studies examine the question of whether late life fertility is heritable, we would have to say that we are not sure of the strength of the genetic relationship. There likely is a genetic determinant, but not necessarily one on which you can depend.
- Philip Chenette, MD


Critical Review    Limitations of Inhibin B Testing

Some patients might have noticed claims that an Inhibin B blood test can better help determine her egg quality. We at Pacific Fertility Center have examined this topic carefully and have chosen not to incorporate this test as a routine procedure.

Currently we use a number of parameters to determine egg quality, or ovarian reserve. For most patients this includes review of:

1. The female partner's age,
2. Results of cycle day 3 FSH and
3. Estradiol (estrogen) testing or
4. A complete clomid challenge test (CCCT), and
5. Ultrasound to determine basal antral follicle count (AFC).

With these parameters we can help determine chances of success with each treatment modality.

We are constantly looking for ways to better determine ovarian reserve. One proposed adjunct is a blood test for Inhibin B. Inhibin B is a protein secreted by the resting antral follicles in the ovary, and is responsible for inhibiting the secretion of FSH in the early part (follicular phase) of the menstrual cycle. There is also a second inhibin called Inhibin A. This inhibin is secreted by the selected and growing follicle in the second (luteal phase) part of the menstrual cycle.

Inhibin B is secreted by the group of small, resting follicles in the ovary and indicates a woman's ovarian reserve. The higher the Inhibin B level, the more ovarian follicles are present in the ovary, the greater the chance of growing a number of follicles with stimulation medications, the greater the chance of achieving a pregnancy. Most studies indicate that an Inhibin B level = 45 pg/ml would indicate adequate ovarian reserve. Inhibin B levels decrease as women age and total follicle numbers decline. Women with very low Inhibin B levels (<20 pg/ml) have such poor ovarian reserve that they have a very high chance of cancellation in an IVF cycle.

Inhibin B is a direct measurement of the hormonal dynamics of the ovarian follicles. FSH testing is an indirect measure of ovarian reserve, but the FSH test is readily available at most reference laboratories. Inhibin B testing is more laborious, and few labs offer this test. Additionally, numerous studies have shown that doing an Inhibin B test alone does not provide more accurate information nor better predict one's ovarian reserve, compared to an FSH test alone. Therefore, these 2 limitations have not allowed for the incorporation of routine Inhibin B testing in a fertility evaluation.
- Isabelle Ryan, MD


Patient Odyssey    Partners: A Donor and A Carrier

My partner, Shannon, and I had always wanted kids. So we went to our doctor to discuss our options for starting a family. She suggested we pick a fertility clinic to get the process started. We chose Pacific Fertility Center. We called the clinic to get started and had hundreds of questions. We spoke with Billie of the New Patient Guides. She was very friendly and more than willing to listen to all our concerns. She suggested we set up our initial consultation with a doctor. We chose Dr. Givens. We met with Dr. Givens in November and were very happy with our visit. Thankfully, we were both healthy and could start the process right away.

We decided we would go with IVF. We wanted to use my eggs for the first pregnancy, as I was nearing 40, but we wanted Shannon to be the carrier. This meant we had a lot of ‘timing' issues to get worked out. To start with, we met with Allison, our IVF Coordinator. She was fantastic- she set up our schedules, talked to us about the different medications, and what the next steps were. We had to get both our cycles in sync, make sure I could produce enough viable eggs at the right time, get them fertilized and implanted into Shannon. WHEW! A lot to do in a short amount of time...

We met with Peggy, the Marriage and Family Therapist, to discuss what exactly the egg donor process meant. (Even though I was donating my eggs to my partner, and would be a co-parent). Peggy asked why we had chosen to go this route; how long we had been together; what were our plans as far as parenting; did I realize that the child, although mine biologically, might very well be closer to Shannon since she was the one giving birth; why did we wait so long to have children (we have been together for 12 years). It was a great re-affirmation that we were doing this for all the right reasons.

We met with Olga, one of the nurses in the clinic, for our injection class. Olga did a great job of making us feel comfortable with this less than desirable task. We started our injections - it was more difficult than we had imagined, but once we got going, it got better.

Dr. Givens started Shannon on birth control to catch her up to my cycle, and when the timing was right, she started on hormone shots. I started on fertility drugs. We moved right through the process. February arrived and it was time for my egg retrieval.

Dr. Chenette did the retrieval. He explained exactly what he would do - the eggs would be taken one by one and given to the lab for fertilization, that it would only take about 15 minutes, what the recovery would be like-very quick and little discomfort, and that in 3 days the fertilized eggs would be transferred into Shannon. I felt very much at ease with Dr. Chenette. Dr. Givens came in to tell us how many eggs had been retrieved and to make sure we were doing OK.

Dr. Chenette also did the embryo transfer. He explained what he was going to do - use a very small catheter to implant the embryo's into Shannon's uterus, what she would feel-very little, if anything, and what to do next. We had 6 eggs that could have been transferred to Shannon, and chose the best 4 - Dr Givens has suggested we transfer 4 embryos to give us a good chance at getting pregnant. We got to watch the transfer and it took all of about 5 minutes! Now it was just a “wait and see” period.

We went back for our pregnancy test 2 weeks after the egg transfer. It was positive!

We had our second pregnancy test 2 days after that, and it was confirmed - we were pregnant. Our next step was an ultrasound at 7 weeks. We had our last ultrasound at 9 weeks and were released to our obstetrician. Much to our dismay, we miscarried.

We are going to try again and wouldn't think of going anywhere else. We are so happy to have worked with such professional and caring people. The staff at Pacific Fertility Center is a fantastic and knowledgeable group and we would absolutely recommend them to anyone who is looking for a fertility clinic.
- Sara and Shannon



Thank you for your interest in subscribing to Pacific Fertility Center's free monthly newsletter. In order to better protect your privacy, we have a new secure subscription/log in form. We respect your privacy: Your email remains confidential and will not be shared or sold. Please click here to change your subscription preferences.

-- Best regards from all of us at Pacific Fertility Center.


Copyright © 2005 Pacific Fertility Center and Its Licensors. All rights reserved.